Following data from the world literature, Gly322Asp polymorphism of hMSH2 gene may enhance the risk of malignancy in the colon or the stomach, as well as increase the incidence rate of lymphomas, anaemia and breast cancer [41–43]. Here, MSH2 is linked to breast carcinoma.